MedPath

The Third Xiangya Hospital of Central South University

The Third Xiangya Hospital of Central South University logo
🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.xy3yy.com

Clinical Trials

66

Active:0
Completed:19

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:1
Phase 2:1
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (39 trials with phase data)• Click on a phase to view related trials

Not Applicable
30 (76.9%)
Phase 4
5 (12.8%)
Early Phase 1
1 (2.6%)
Phase 1
1 (2.6%)
Phase 2
1 (2.6%)
Phase 3
1 (2.6%)

The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients

Not Applicable
Not yet recruiting
Conditions
NSCLC
Sintilimab
Adaptive Radiotherapy
Interventions
Drug: Experimental
First Posted Date
2025-08-24
Last Posted Date
2025-08-24
Lead Sponsor
The Third Xiangya Hospital of Central South University
Target Recruit Count
35
Registration Number
NCT07138755

Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease

Not Applicable
Recruiting
Conditions
Mild to Severe Crohns Disease
First Posted Date
2025-08-14
Last Posted Date
2025-08-14
Lead Sponsor
The Third Xiangya Hospital of Central South University
Target Recruit Count
24
Registration Number
NCT07123207
Locations
🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

Recruiting
Conditions
Predictor
Crohn Disease (CD)
Vedolizumab
Intestinal Ultrasound
First Posted Date
2025-07-30
Last Posted Date
2025-07-30
Lead Sponsor
The Third Xiangya Hospital of Central South University
Target Recruit Count
60
Registration Number
NCT07093294
Locations
🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Establishment of a Classification System and Postoperative Risk Warning Model for Patients Undergoing Bariatric Metabolic Surgery for Severe Obesity

Recruiting
Conditions
Bariatric Surgery (Sleeve Gastrectomy )
Obesity
Bariatric Surgery
First Posted Date
2025-07-30
Last Posted Date
2025-07-30
Lead Sponsor
The Third Xiangya Hospital of Central South University
Target Recruit Count
2000
Registration Number
NCT07093502
Locations
🇨🇳

Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients

Recruiting
Conditions
Acute Myocardial Infarction (AMI)
First Posted Date
2025-06-29
Last Posted Date
2025-07-02
Lead Sponsor
The Third Xiangya Hospital of Central South University
Target Recruit Count
300
Registration Number
NCT07042321
Locations
🇨🇳

Xiangya Third Hospital of Central South University, Changsha, Hunan Province,China, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.